Production (Stage)
Predictmedix AI Inc.
PMED
CNSX
04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 625.50K | 573.10K | 689.40K | 840.70K | 1.15M |
Depreciation & Amortization | 87.60K | 112.80K | 116.60K | 119.00K | 122.00K |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 713.10K | 685.90K | 806.10K | 959.80K | 1.28M |
Operating Income | -713.10K | -685.90K | -806.10K | -959.80K | -1.28M |
Income Before Tax | -876.30K | -850.10K | -840.70K | -997.50K | -1.33M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -0.88 | -0.85 | -0.84 | -1.00 | -1.33 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -876.30K | -850.10K | -840.70K | -997.50K | -1.33M |
EBIT | -713.10K | -685.90K | -806.10K | -959.80K | -1.28M |
EBITDA | -604.80K | -575.90K | -759.40K | -887.40K | -1.15M |
EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
Average Basic Shares Outstanding | 625.26M | 601.04M | 601.12M | 598.71M | 588.68M |
Average Diluted Shares Outstanding | 625.26M | 601.04M | 601.12M | 598.71M | 588.68M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |